US 10617674
Dosage regimen for the treatment of acute exacerbations of inflammatory conditions
granted A61KA61K31/415A61K9/0053
Quick answer
US patent 10617674 (Dosage regimen for the treatment of acute exacerbations of inflammatory conditions) held by MEREO BIOPHARMA 1 LIMITED expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MEREO BIOPHARMA 1 LIMITED
- Grant date
- Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/415, A61K9/0053, A61P, A61P11/00